Multistate Infant Botulism Outbreak Associated with Powdered Infant Formula

Connie H Chung1, Jason R Barash2, Jacquelin L Castonguay1

  • 1Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, California Department of Public Health, Richmond, CA, USA.

NEJM Evidence
|February 25, 2026
PubMed

Insights

An infant botulism outbreak in the United States was linked to ByHeart powdered infant formula. This led to a nationwide recall of the product after 51 cases were identified.

Area of Science:

  • Public Health
  • Microbiology
  • Epidemiology

Background:

  • Infant botulism is a rare but serious illness caused by Clostridium botulinum spores.
  • Powdered infant formula has been previously identified as a potential source of infant botulism.

Purpose of the Study:

  • To identify the source of an outbreak of infant botulism.
  • To investigate the association between Clostridium botulinum type A and powdered infant formula.

Main Methods:

  • Case finding through the Infant Botulism Treatment and Prevention Program, California Department of Public Health (IBTPP-CDPH).
  • Laboratory analysis of powdered infant formula samples.
  • Epidemiological investigation to determine exposure history.

Main Results:

  • Clostridium botulinum type A was identified in ByHeart powdered infant formula.
  • A common exposure to ByHeart powdered infant formula was noted among affected neonates.
  • As of December 10, 2025, 51 cases of infant botulism linked to this formula were reported across 19 states.

Conclusions:

  • Powdered infant formula can be a vehicle for Clostridium botulinum transmission.
  • Prompt identification and public health intervention, including product recall, are crucial in managing outbreaks.
  • Continued surveillance and research are necessary to prevent future infant botulism cases associated with infant nutrition products.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
400
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
635
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
37